Barrow Robert
Chief Executive Officer, Director
10 filings on record here, covering DFTX, PALI, LFST, MIAC, PHIN, OKTA. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Award | DFTX | Definium Therapeutics, Inc. | |
CORPORATEFiled 2026-07-10
| Buy | PALI | PALISADE BIO, INC. | $39,798 |
| Buy | PALI | PALISADE BIO, INC. | $48,900 |
CORPORATEFiled 2026-07-08
| Buy | PALI | PALISADE BIO, INC. | $41,040 |
| Buy | PALI | PALISADE BIO, INC. | $61,044 |
CORPORATEFiled 2026-07-07
| Award | LFST | LifeStance Health Group, Inc. | |
CORPORATEFiled 2026-07-07
| Other | MIAC | Meridian3 Industrials Acquisition Corp | $11,906 |
| Other | MIAC | Meridian3 Industrials Acquisition Corp | $3,969 |
| Other | MIAC | Meridian3 Industrials Acquisition Corp | $3,750,000 |
| Other | MIAC | Meridian3 Industrials Acquisition Corp | $750,000 |
| Other | MIAC | Meridian3 Industrials Acquisition Corp | $250,000 |
CORPORATEFiled 2026-07-06
| Buy | PALI | PALISADE BIO, INC. | $39,600 |
| Buy | PALI | PALISADE BIO, INC. | $19,800 |
CORPORATEFiled 2026-06-30
| Sell | LFST | LifeStance Health Group, Inc. | $4,529,812 |
| Sell | LFST | LifeStance Health Group, Inc. | $4,529,822 |
CORPORATEFiled 2026-06-25
CORPORATEFiled 2026-06-22
CORPORATEFiled 2026-06-22
| Award | DFTX | Definium Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.